Webinar Seven
Dengue Analytics & Clinical Development Of Vaccine V181 Update
Webinar Six
PREDICTORS OF SEVERE DENGUE – WHAT’S NEW?
Webinar Five
PRE-VACCINATION SCREENING – WHAT’S NEXT?
| Date: | 15th November 2021 |
| Topic: | PRE-VACCINATION SCREENING - WHAT’S NEXT? |
| Time: | 1500 – 1630 (Malaysia Time) |
| Co-Chairs: | Prof Zulkifli Ismail Clinical Professor, KPJ Healthcare University College, Malaysia Dr. Maria Rosario Capeding Head, Medical Research Unit Tropical Disease Foundation Philippines Steering Committe Member,Asia Dengue Voice and Action Group |
| Speakers and Topic title |
Topic title: Dengue diagnostic tests: An update Prof. Sutee Yoksan Emeritus Professor of Pathobiology and Consultant of Center for Vaccine Development, Institute of Molecular Biosciences, Mahidol University, Thailand Topic title: Strategies for Dengue pre-vaccination screening Prof Usa Thisyakorn Executive Director, Tropical Medicine Cluster, Chulalongkorn University, Bangkok, Thailand Steering committee member, Asia Dengue Voice & Action Group |
Webinar Four
Strategies for Vector Control – The Wolbachia Story
| Date: | 15 September 2021 |
| Topic: | STRATEGIES FOR VECTOR CONTROL - THE WOLBACHIA STORY |
| Time: | 1500 – 1630 (Malaysia Time) |
| Co-Chairs: | Prof Zulkifli Ismail Clinical Professor, KPJ Healthcare University College, Malaysia Prof. Sri Rezeki Hadinegoro Vice Chairman University of Indonesia Indonesia |
| Speakers: | Ms Sakunthala Janaki Entomologist, National Dengue Control Unit Ministry of Health Sri Lanka Dr Norhayati Mokhtar Public Health Specialist Senior Principal Assistant Director (Dengue) Vector Borne Disease Sector Disease Control Division Ministry of Health Malaysia Dr Claudia Surjadjaj Regional Director Asia World Mosquito Program (WMP) |
Webinar Three
IMPACT OF THE COVID-19 PANDEMIC ON THE GLOBAL DENGUE SITUATION
| Date: | 20th Jan 2021 |
| Topic: | Managing the severely ill dengue patients – Adult and Paediatric Intensivists |
| Time: | 7pm to 8:30pm Bangkok Time / 8pm to 9:30pm Kuala Lumpur Time |
| Co-Chairs: | Prof Zulkifli Ismail Clinical Professor, KPJ Healthcare University College, Malaysia Prof Duane J Gubler Professor and Founding Director Signature Research Programme in Emerging Infectious Disease Duke-NUS Graduate Medical School, Singapore |
| Speakers: | Dr Ng Lee Ching Director National Environment Agency’s Environmental Health Institute, Singapore Dr Hasitha Tissera Specialist Medical Epidemiologist, Ministry of Health, Sri Lanka |
Webinar Two
Managing the severely ill dengue patients – Adult and Paediatric Intensivists
| Date: | 20th Jan 2021 |
| Topic: | Managing the severely ill dengue patients – Adult and Paediatric Intensivists |
| Time: | 7pm to 8:30pm Bangkok Time / 8pm to 9:30pm Kuala Lumpur Time |
| Co-Chairs: | Prof Usa Thisyakorn Prof Zulkifli Ismail |
| Speakers: | Prof Terapong Prof Lucy Lum Prof Bridget Wills |
Webinar One
Randomised trials of Wolbachia for dengue control – a step towards elimination?
| Speaker: | Prof. Cameron Simmons (World Mosquito Program) |
| Chairperson: | Prof. Ooi Eng Eong (Duke- National University of Singapore Medical School) |
| Panelists: | Assoc Prof. Ng Lee Ching (Group Director, Environmental Health Institute National, Environmental Agency Singapore) Prof. Sri Rezeki Hadinegoro (Vice Chairperson, Asian Dengue Voice and Action (ADVA) Group Steering Committee) Prof. Adi Utarini (Project Leader & PI, World Mosquito Program) |
| Title of session: | Randomised Trials of Wolbachia for Dengue Control – A Step Towards Elimination? |
| Date: | 28th October 2020 |
| Time: | 1700 – 1830 hrs (SGT GMT+08:00) |
| Networking sessions: |
1630 – 1700 & 1830 – 1900 hrs (SGT GMT+08:00) |
Decimate Dengue: Randomised Trials of Wolbachia for Dengue Control – A Step Towards Elimination?
Randomised Trials of Wolbachia for Dengue Control – A Step Towards Elimination? – Discussion
00:00 – Introduction to Panelists by Chairperson Prof. Ooi Eng Eong –
00:50 – Panelists’ first impression of Prof. Simmons’ findings –
04:18 Prof. Ooi: “What were the responses from the residents, local government and health officials of Yogyakarta, and what’s next?”
05:45 Prof. Ooi: “What are some of your impressions and how do you see the impact on ASEAN and other parts of the world?”
08:27 – A multi-part question from Prof. Ng Lee Ching, Environmental Health Insitutute, Singapore … –
11:39 Webinar participant: “What were the differences between the release strategy in Indonesia vis-a-vis in Vietnam that made the Indonesia release more successful?”
12:49 Webinar participant: “How did you convince local authorities and residents of Yogyakarta to get on board with the release of more mosquitoes into their environment?”
16:55 Webinar participant: “Was there a dengue outbreak in the city during the period when the trial was conducted?”
18:53 Webinar participant: “What is the future of arbovirus control? Should public health programs focus on one method or a set of them?”
23:06 Webinar participant: “Did you continue to educate residents on source reduction or allow residents to adopt less vigilant approach knowing that the Wolbachia mosquito will do the job? Are residents and premises owners like construction sites fined when mosquito breeding is detected in their premises?” 25:12 Webinar participant: “Did the dengue vaccine controversy pose any challenges to the carrying out of the study?”
25:38 Webinar participant: “How do you know that the eggs will hatch? How many hatched?”
26:02 Prof. Ooi: “Is there a need for bridging studies to determine the effectiveness of this program in different parts of the world?”
27:30 Webinar participant: “What is the status of decreasing vectorial capacity of albopictus by Wolbachia superinfection or other means?”
29:27 Webinar participant: “I saw that the mosquito population index has one peak a year. In Singapore we have seen 2 peaks in a year from our gravitrap surveillance network. Do you know what drives the mosquito population up and down?”
31:37 Webinar participant: “In raising your Wolbachia infected mosquito stocks, is there an alternative to human volunteers as a blood source?”
33:11 End of Discussion – Closing Remarks